Yuanbo Liu
4PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Feb 21, 2022
The PI3K/AKT/mTOR signaling pathway is aberrantly activated in primary central nervous system lymphoma and correlated with a poor prognosis.Xiaowei Zhang, Yuchen Wu, Xuefei Sun
|Apr 02, 2021
Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study.Yuchen Wu, Xuefei Sun, Xueyan Bai
|Jun 14, 2020
Expression of hypoxia-inducible factor 1α, glucose transporter 1, and hexokinase 2 in primary central nervous system lymphoma and the correlation with the biological behaviors.Na Shen, Yaming Wang, Xuefei Sun
Pageof 1
